Name Of Patient : MR.

RAGHAV GUPTA
Received Date & Time : 02/06/2022 08:32:25
Age : 09 Yrs Gender : Male
Printing Date & Time : 02/06/2022 19:43:55
Ref. By Dr. Patient ID : 14213560 Ref. By Lab :
Company : PRIVATE DOCTOR
ID No : 905757122692 SRF ID : 0708301538683

Test Name Value Unit Biological Ref Interval

MOLECULAR*
COVID-19 VIRUS QUALITATIVE PCR*
FINAL RESULT OF SARS-CoV2 (COVID19) NEGATIVE
Interpretation
Result Interpretation
Positive RNA specific to SARS-CoV-2 Detected
Negative RNA specific to SARS-CoV-2 not detected
Inconclusive This could be due to presence of inhibitors in the sample. A repeat sample is
recommended in such cases
Indeterminate Kindly correlate with duration of illness and send a repeat sample after 3-5 days

NOTE
1. ICMR Registration number for Covid -19 is UPDGND
2. Covid-19 Test conducted as per kits approved by ICMR / CE-IVD / USFDA
3. Real Time RT-PCR is the gold standard Frontline test for diagnosis of COVID-19.
4. COVID-19 is a Notifiable Disease. Detected positive cases have to follow the MOHFW guidelines of strict home isolation
along with other safety measures. Their presence in social places should be subject to as offensive action. The lab cannot
be held responsible for their any such action.
5. Target genes specific for SARS -CoV-2 included in the assay are : E/N gene, RdRp/ORF1 gene.
6. Confirmatory assay is performed and NOT just The SCREENING one
7. TAT is minimum 6 hrs and maximum 24 hrs varying on the sample collection site.
8. Test integrity check points :Strict cold chain maintained &Internal control gene used
9. Negative result does not rule out the possibility of Covid-19 infection. Presence of inhibitors, mutations & insufficient RNA
specific to SARS-CoV-2 can influence the test result. Kindly correlate the results with clinical findings. A negative result in a
single upper respiratory tract sample does not rule out SARS-CoV-2 infection. Hence in such cases a repeat sample should
be sent. If a subsequent sample is tested positive(DETECTED), it may indicate an infection acquired subsequently/increase
in viral load to detectable limit after the first test. Lower respiratory tract samples like Sputum, BAL, ET aspirate are
appropriate samples especially in severe and progressive lung disease.
10. Optimum specimen types and timing for peak viral levels during infections caused by 2019-nCoV have not been determined.
Collection of multiple specimens (types and time points) from the same patient may be necessary to detect the virus.Note:
The results relate only to the specimens tested and should be correlated with clinical findings and the duration of illness.
11. Testing of referred clinical specimens was considered on the basis of request / referral received from / through State

DR. NEHA JAIN

MD, DNB, MNAMS
Consultant Microbiologist
..